In summary, the differential diagnosis of TC includes SCC, BCC, and sebaceous carcinoma, among others. Immunohistochemistry typically shows CD34 positivity and EMA negativity. Genetically, TC often harbors TP53 mutations and other alterations common in skin cancers, which may influence its clinical behavior and treatment options. This evidence concerns the gene MUC1 and skin neoplasm.